全文获取类型
收费全文 | 3222篇 |
免费 | 160篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 130篇 |
妇产科学 | 34篇 |
基础医学 | 370篇 |
口腔科学 | 73篇 |
临床医学 | 319篇 |
内科学 | 550篇 |
皮肤病学 | 62篇 |
神经病学 | 218篇 |
特种医学 | 93篇 |
外科学 | 784篇 |
综合类 | 61篇 |
一般理论 | 4篇 |
预防医学 | 126篇 |
眼科学 | 135篇 |
药学 | 193篇 |
中国医学 | 13篇 |
肿瘤学 | 230篇 |
出版年
2023年 | 36篇 |
2022年 | 78篇 |
2021年 | 135篇 |
2020年 | 60篇 |
2019年 | 115篇 |
2018年 | 115篇 |
2017年 | 90篇 |
2016年 | 90篇 |
2015年 | 92篇 |
2014年 | 146篇 |
2013年 | 138篇 |
2012年 | 252篇 |
2011年 | 242篇 |
2010年 | 142篇 |
2009年 | 115篇 |
2008年 | 184篇 |
2007年 | 190篇 |
2006年 | 193篇 |
2005年 | 179篇 |
2004年 | 178篇 |
2003年 | 120篇 |
2002年 | 108篇 |
2001年 | 48篇 |
2000年 | 49篇 |
1999年 | 36篇 |
1998年 | 17篇 |
1997年 | 16篇 |
1996年 | 21篇 |
1995年 | 18篇 |
1994年 | 16篇 |
1993年 | 11篇 |
1992年 | 20篇 |
1991年 | 19篇 |
1990年 | 15篇 |
1989年 | 15篇 |
1988年 | 11篇 |
1987年 | 10篇 |
1986年 | 13篇 |
1985年 | 9篇 |
1984年 | 8篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1980年 | 6篇 |
1979年 | 7篇 |
1978年 | 4篇 |
1976年 | 5篇 |
1974年 | 12篇 |
1973年 | 5篇 |
1972年 | 5篇 |
1970年 | 6篇 |
排序方式: 共有3438条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
Michele Raja Antonella Azzoni 《International journal of psychiatry in clinical practice》2013,17(2):146-148
Objective. To point out the danger of worsening mood disorders with the use of hypericum. Methods. Longitudinal clinical observation of two cases treated with hypericum. Results. The two patients underwent mixed episodes following hypericum treatment. One of them needed hospitalization for suicidal risk. Conclusion. Caution is warranted in the use of hypericum in depressed patients with hidden bipolarity. Patients should be informed that hypericum may induce manic symptoms, increase cycling of mood states, or worsen the depressive state. 相似文献
75.
R. V. Kishore Kumar Sathya Kumar Devireddy Raja Sekhar Gali Nemaly Chaithanyaa Sridhar 《Journal of maxillofacial and oral surgery》2013,12(1):21-29
Introduction
Injuries of the facial soft tissues may be due to road traffic accidents, industrial injuries, domestic and interpersonal violence, dog bites, human bites, war injuries etc. They may be described depending on the depth of involvement of the soft tissue and/or region since it gives the clinician the method of treatment. The soft tissue injuries must take into the underlying skeletal injury into account since these injuries if carelessly handled they leave deformed scarring in the most precious and beautiful part of the body.Materials and Methods
Various patients reporting to the department of Oral and Maxillofacial Surgery, Narayana Dental College and hospital, Nellore were included in the study. Injuries in the various aspects of face at various anatomical areas has been presented with the mode of management.Conclusion
The maxillofacial surgeon while attending these cases should avoid the need for revision by having a thorough knowledge of the anatomy, physiology of the soft tissues and treat them accordingly after following good clinical and radiological examination. 相似文献76.
Raja KalayarasanAmit Javed M.S. M.Ch. Puja SakhujaAnil K. Agarwal M.S. M.Ch. 《American journal of surgery》2013
Background
Literature on squamous variants of gallbladder cancer (GBC) is limited.Methods
This was a retrospective analysis of GBC patients operated on between August 2009 and March 2012. Patients with adenosquamous carcinoma or squamous cell carcinoma were compared with adenocarcinoma for clinicopathologic features and surgical outcomes.Results
Of the primary GBC patients resected with curative intent, 14 had adenosquamous carcinoma (10) or squamous cell carcinoma (4) (group A), whereas 122 had adenocarcinoma (group B). Abdominal pain was the most common symptom in both groups; however, presentation with vomiting and an abdominal lump was more common in group A (P = .04 and <.01, respectively). Group A had a significantly larger tumor size (7.9 vs 4.8 cm, P = .01) and a higher incidence of adjacent organ involvement requiring extended resections (85.7% vs 26.2%, P < .01). Despite the higher T stage, node-negative disease was significantly higher in group A (42.9% vs 17.2%, P = .03). There was no significant difference in the median survival after curative resection between the 2 groups (28 vs 31 months, P = .24).Conclusions
The squamous variant of GBC presented at an advanced T stage; however, nodal involvement and distant metastasis were less common. Despite the higher T stage, curative resection could be achieved in the majority with a comparable survival. 相似文献77.
78.
79.
A Besarab SN Zeig ER Martin PE Pergola FC Whittier RI Zabaneh B Schiller M Mayo CA Francisco KR Polu AM Duliege 《BMC nephrology》2012,13(1):95
ABSTRACT: BACKGROUND: Peginesatide is a peptide-based erythropoiesis-stimulating agent that was designed and engineered to stimulate specifically the erythropoietin receptor dimer that governs erythropoiesis. The primary objective of this phase 2 dose-finding study was to determine the once-monthly peginesatide dosing strategy that would maintain hemoglobin within [PLUS-MINUS SIGN]1.0 g/dL of baseline values after conversion from epoetin alfa; the safety of peginesatide was evaluated concurrently. METHODS: Chronic hemodialysis patients on stable regimens of epoetin alfa were sequentially assigned to cohorts that differed on (1) how the peginesatide starting dose was determined (using a single epoetin alfa--to-peginesatide dose conversion ratio or a tiered, weight-based or absolute-dose conversion table) and on (2) whether or not a 1-week erythropoiesis-stimulating agent-free interval was used. Peginesatide doses were titrated to maintain hemoglobin levels within [PLUS-MINUS SIGN]1.0 g/dL from baseline. RESULTS: A total of 164 patients were enrolled and received intravenous peginesatide every 4 weeks for up to 6 doses; the duration of the study including follow-up was [LESS-THAN OR EQUAL TO]29 weeks. Overall, the proportion of patients with hemoglobin levels within [PLUS-MINUS SIGN]1.0 g/dL of baseline increased over the course of the study from 39% (Weeks 2--13) to 54% (Weeks 18--25). Cohorts that used tiered dose conversion tables trended towards having more stable peginesatide doses than did those cohorts that used a single dose conversion ratio. Moreover, cohorts that used an erythropoiesis-stimulating agent-free interval did not have the substantial initial increase in hemoglobin levels that was seen in those cohorts that did not use such an interval. In this study, the safety profile of peginesatide was consistent with those of marketed erythropoiesis-stimulating agents. CONCLUSIONS: The results of this study were used to guide the dosing regimens used subsequently in phase 3 studies. Once-monthly peginesatide is feasible in hemodialysis patients.Trial registrationClinicalTrials.gov registration: NCT00228449. 相似文献
80.
Vivek Pravin Dave Mudit Tyagi Raja Narayanan Rajeev Reddy Pappuru 《Indian journal of ophthalmology》2021,69(1):14
Optimal visualization is one of the most challenging aspects of performing vitreoretinal surgery. In situations where conventional microscopic techniques provide poor posterior visualization, the adjunctive skill set of endoscopic visualization may be needed. This allows for by-passing the opaque anterior segment media and getting access to the posterior segment pathology. Endoscopic vitrectomy is a useful and unique adjunct to microincision vitreoretinal surgery. The optical set-up of endoscopy allows for clinical approaches that are impossible with regular microscope viewing systems. These include the ability to observe across optically significant anterior segment opacities and directly visualize the posterior segment of the eye. It also allows for visualizing the difficult-to-access retroirideal, retrolental, and anterior retinal structures. Surgical access to anatomic spaces like the pars plana, pars plicata, ciliary sulcus, ciliary body, and peripheral lens is tedious. This is made simpler by endoscopy. In this review, we summarize and review the usage of the intraocular endoscope as a diagnostic and therapeutic armamentarium across a wide spectrum of ocular pathologies. 相似文献